Vanguard Report: The future role of laboratories in relation to antimicrobial resistance

28th September 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, David Wells explores the future role of laboratories in relation to antimicrobial resistance...

Vanguard Report: Drug development and the tension between access and excess

21st September 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Santanu Datta explores the future of drug development and the tension between access and excess…

Vanguard Report: The future of drug development

10th August 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Laura Piddock explores the challenges involved in re-stimulating the antimicrobial drug development market…

Vanguard Report: Inequality and antibiotic resistance

1st July 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Marc Mendelson explores the inequality that lies at the heart of antibiotic resistance, and explains why “no one is safe until we are all safe”...

Vanguard Report: The future of antibiotic stewardship: managing access and excess

23rd June 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Debra Goff explores the future of of antibiotic stewardship...

Vanguard Report: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries

27th May 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Daniel Berman and Ruth Neale explore the future of AMR diagnostics...

Vanguard Report: Antimicrobial resistance and the future of diagnostic testing

28th April 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Prof Gail Hayward and Dr Philip Turner explore the future of diagnostic testing...

From Treatment Options to Precision Medicine: The Future of “Omics-Based” Antibiotic Resistance Surveillance Data

1st April 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Professor Sabiha Essack, explores the future of infection prevention and control...

The future of IPC: how COVID is already transforming our approach to AMR

25th February 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Andreas Voss, Professor of Infection Control at Radboud University, explores the future of infection prevention and control...

Lindsay Denny: Clean water – the world’s best medicine for disease and drug-resistant infection

11th February 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance.

Dame Sally Davies: Are we finally finding our voice on AMR?

2nd February 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance.

Michael T. Osterholm: the future of ADVOCACY on AMR

11th January 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Dr Michael T. Osterholm describes how we can all become advocates for a new and better future, in spite of the increasingly complex threat of antimicrobial resistance...

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top